Common Contracts
10 similar License to Publish contracts
License to PublishLicense to Publish • November 14th, 2022
By signing this License to Publish agreement, you (the “Author”) grant Open Exploration Publishing Inc. (the “Publisher”, “we/us”) as the original Publisher to publish the above article in Exploration of Diabetes, Endocrinology and Metabolism (the “Journal”), including but not limited to, abstract, text, figures, tables and supplementary materials on an Open Access basis. You grant to us the perpetual, non-exclusive right throughout the world to edit, adapt, translate, publish, reproduce, distribute and display the article in printed, electronic form or any other medium and format whether now known or yet to be developed; you agree to allow us to publish the article and associated supplementary materials under the terms of the Creative Commons Attribution 4.0 International License (CC BY, https://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium or format, provided that the users give appropriate credit, provide a link to the license,
Standard Contracts
License to PublishLicense to Publish • September 26th, 2022
By signing this License to Publish agreement, you (the “Author”) grant Open Exploration Publishing Inc. (the “Publisher”, “we/us”) as the original Publisher to publish the above article in Exploration of Digital Health Technologies (the “Journal”), including but not limited to, abstract, text, figures, tables and supplementary materials on an Open Access basis. You grant to us the perpetual,
License to PublishLicense to Publish • September 5th, 2022
By signing this License to Publish agreement, you (the “Author”) grant Open Exploration Publishing Inc. (the “Publisher”, “we/us”) as the original Publisher to publish the above article in Exploration of BioMat-X (the “Journal”), including but not limited to, abstract, text, figures, tables and supplementary materials on an Open Access basis. You grant to us the perpetual,
License to PublishLicense to Publish • June 17th, 2022
By signing this License to Publish agreement, you (the “Author”) grant Open Exploration Publishing Inc. (the “Publisher”, “we/us”) as the original Publisher to publish the above article in Exploration of Foods and Foodomics (the “Journal”), including but not limited to, abstract, text, figures, tables and supplementary materials on an Open Access basis. You grant to us the perpetual,
License to PublishLicense to Publish • April 26th, 2022
By signing this License to Publish agreement, you (the “Author”) grant Open Exploration Publishing Inc. (the “Publisher”, “we/us”) as the original Publisher to publish the above article in Exploration of Drug Science (the “Journal”), including but not limited to, abstract, text, figures, tables and supplementary materials on an Open Access basis. You grant to us the perpetual, non-exclusive right throughout the world to edit, adapt, translate, publish, reproduce, distribute and display the article in printed, electronic form or any other medium and format whether now known or yet to be developed; you agree to allow us to publish the article and associated supplementary materials under the terms of the Creative Commons Attribution 4.0 International License (CC BY, https://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium or format, provided that the users give appropriate credit, provide a link to the license, and indicate if changes w
License to PublishLicense to Publish • December 27th, 2021
By signing this License to Publish agreement, you (the “Author”) grant Open Exploration Publishing Inc. (the “Publisher”, “we/us”) as the original Publisher to publish the above article in Exploration of Asthma & Allergy (the “Journal”), including but not limited to, abstract, text, figures, tables and supplementary materials on an Open Access basis. You grant to us the perpetual, non-exclusive right throughout the world to edit, adapt, translate, publish, reproduce, distribute and display the article in printed, electronic form or any other medium and format whether now known or yet to be developed; you agree to allow us to publish the article and associated supplementary materials under the terms of the Creative Commons Attribution 4.0 International License (CC BY, https://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium or format, provided that the users give appropriate credit, provide a link to the license, and indicate if chang
License to PublishLicense to Publish • February 20th, 2021
By signing this License to Publish agreement, you (the “Author”) grant Open Exploration Publishing Inc. (the “Publisher”,“we/us”) as the original Publisher to publish the above article in Exploration of Immunology(the “Journal”), including but not limited to, abstract, text, figures, tables and supplementary materials on an Open Access basis. You grant to us the perpetual, non-exclusive right throughout the world to edit, adapt, translate, publish, reproduce, distribute and display the article in printed, electronic form or any other medium and format whether now known or yet to be developed; you agree to allow us to publish the article and associated supplementary materials under the terms of the Creative Commons Attribution 4.0 International License(CC BY, https://creativecommons.org/licenses/by/4.0/),which permits use, distribution and reproduction in any medium or format, provided that the users give appropriate credit, provide a link to the license, and indicate if changes were ma
License to PublishLicense to Publish • January 6th, 2021
By signing this License to Publish agreement, you (the “Author”) grant Open Exploration Publishing Inc. (the “Publisher”, “we/us”) as the original Publisher to publish the above article in Exploration of Neuroprotective Therapy (the “Journal”), including but not limited to, abstract, text, figures, tables and supplementary materials on an Open Access basis. You grant to us the perpetual, non-exclusive right throughout the world to edit, adapt, translate, publish, reproduce, distribute and display the article in printed, electronic form or any other medium and format whether now known or yet to be developed; you agree to allow us to publish the article and associated supplementary materials under the terms of the Creative Commons Attribution 4.0 International License (CC BY, https://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium or format, provided that the users give appropriate credit, provide a link to the license, and indicate i
License to PublishLicense to Publish • January 6th, 2021
By signing this License to Publish agreement, you (the “Author”) grant Open Exploration Publishing Inc. (the “Publisher”, “we/us”) as the original Publisher to publish the above article in Exploration of Medicine (the “Journal”), including but not limited to, abstract, text, figures, tables and supplementary materials on an Open Access basis. You grant to us the perpetual, non-exclusive right throughout the world to edit, adapt, translate, publish, reproduce, distribute and display the article in printed, electronic form or any other medium and format whether now known or yet to be developed; you agree to allow us to publish the article and associated supplementary materials under the terms of the Creative Commons Attribution 4.0 International License (CC BY, https://creativecommons.org/licenses/by/4.0/), which permits use, distribution and reproduction in any medium or format, provided that the users give appropriate credit, provide a link to the license, and indicate if changes were
License to PublishLicense to Publish • January 6th, 2021
By signing this License to Publish agreement, you (the “Author”) grant Open Exploration Publishing Inc. (the “Publisher”, “we/us”) as the original Publisher to publish the above article in Exploration of Targeted Anti-tumor Therapy (the “Journal”), including but not limited to, abstract, text, figures, tables and supplementary materials on an Open Access basis. You grant to us the perpetual,
